Nicole K Zhang, Selena K Zhang, Li I Zhang, Huizhong W Tao, Guang-Wei Zhang
{"title":"The neural basis of neuropsychiatric symptoms in Alzheimer's disease.","authors":"Nicole K Zhang, Selena K Zhang, Li I Zhang, Huizhong W Tao, Guang-Wei Zhang","doi":"10.3389/fnagi.2024.1487875","DOIUrl":null,"url":null,"abstract":"<p><p>Neuropsychiatric symptoms (NPS) such as depression, anxiety, apathy and aggression affect up to 90% of Alzheimer's disease (AD) patients. These symptoms significantly increase caregiver stress and institutionalization rates, and more importantly they are correlated with faster cognitive decline. However, the neuronal basis of NPS in AD remains largely unknown. Here, we review current understanding of NPS and related pathology in studies of AD patients and AD mouse models. Clinical studies indicate that NPS prevalence and severity vary across different AD stages and types. Neuroimaging and postmortem studies have suggested that pathological changes in the anterior cingulate cortex, hippocampus, prefrontal cortex, and amygdala are linked to NPS, although the precise mechanisms remain unclear. Studies of AD mouse models have indicated that amyloid-beta and tau-related neurodegeneration in the hippocampus, prefrontal cortex, and anterior cingulate cortex are correlated with NPS-like behavioral deficits. A better understanding of the NPS phenotypes and related pathological changes will pave the way for developing a better management strategy for NPS in AD patients.</p>","PeriodicalId":12450,"journal":{"name":"Frontiers in Aging Neuroscience","volume":"16 ","pages":"1487875"},"PeriodicalIF":4.1000,"publicationDate":"2024-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11655510/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Aging Neuroscience","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fnagi.2024.1487875","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"GERIATRICS & GERONTOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
抑郁、焦虑、冷漠和攻击性等神经精神症状(NPS)影响着高达 90% 的阿尔茨海默病(AD)患者。这些症状大大增加了照顾者的压力和入院率,更重要的是,它们与认知能力的加速衰退有关。然而,NPS 在阿尔茨海默病中的神经元基础在很大程度上仍然未知。在此,我们回顾了目前对 NPS 及其相关病理的理解,以及对 AD 患者和 AD 小鼠模型的研究。临床研究表明,NPS的患病率和严重程度在不同的AD阶段和类型中有所不同。神经影像学和尸检研究表明,前扣带回皮层、海马、前额叶皮层和杏仁核的病理变化与 NPS 有关,但其确切机制仍不清楚。对注意力缺失症小鼠模型的研究表明,海马、前额叶皮层和前扣带皮层中与淀粉样蛋白-β和tau相关的神经退行性变与NPS样行为缺陷相关。更好地了解NPS表型和相关病理变化将为制定更好的AD患者NPS管理策略铺平道路。
The neural basis of neuropsychiatric symptoms in Alzheimer's disease.
Neuropsychiatric symptoms (NPS) such as depression, anxiety, apathy and aggression affect up to 90% of Alzheimer's disease (AD) patients. These symptoms significantly increase caregiver stress and institutionalization rates, and more importantly they are correlated with faster cognitive decline. However, the neuronal basis of NPS in AD remains largely unknown. Here, we review current understanding of NPS and related pathology in studies of AD patients and AD mouse models. Clinical studies indicate that NPS prevalence and severity vary across different AD stages and types. Neuroimaging and postmortem studies have suggested that pathological changes in the anterior cingulate cortex, hippocampus, prefrontal cortex, and amygdala are linked to NPS, although the precise mechanisms remain unclear. Studies of AD mouse models have indicated that amyloid-beta and tau-related neurodegeneration in the hippocampus, prefrontal cortex, and anterior cingulate cortex are correlated with NPS-like behavioral deficits. A better understanding of the NPS phenotypes and related pathological changes will pave the way for developing a better management strategy for NPS in AD patients.
期刊介绍:
Frontiers in Aging Neuroscience is a leading journal in its field, publishing rigorously peer-reviewed research that advances our understanding of the mechanisms of Central Nervous System aging and age-related neural diseases. Specialty Chief Editor Thomas Wisniewski at the New York University School of Medicine is supported by an outstanding Editorial Board of international researchers. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.